Reproductive hormones play vital roles in reproductive
health and
can be used to assess a woman’s ovarian function and diagnose
diseases associated with reproductive endocrine disorders. As these
hormones are important biomarkers for reproductive health monitoring
and diagnosis, a rapid, high-throughput, and low-invasive detection
and simultaneous assessment of the levels of multiple reproductive
hormones has important clinical applications. In this work, a quadruplex
ultrasensitive immunoassay was developed for simultaneous assessment
of 4 human reproductive hormone proteins (follicle-stimulating hormone
(FSH), luteinizing hormone (LH), prolactin (PRL), and anti-Müllerian
hormone (AMH)) in a variety of human biofluid samples. This assay
takes advantage of single-molecule imaging of microwell arrays and
capture antibody beads as a reaction interface to construct multiplex
bead array immunoassays. The analyte-bound beads can easily be parsed
to individual wells and detected via fluorophores, emitting distinct
wavelengths associated to the beads. As a result, this proposed quadruplex
immunoassay exhibits four good 4-parameter logistic calibration curves
ranging from 2.7 to 2000, 1.6 to 1200, 1.8 to 1300, and 0.3 to 220
pg/mL with limits of detection of 0.32, 0.28, 0.14, and 0.02 pg/mL
for FSH, LH, PRL, and AMH, respectively. Furthermore, the developed
quadruplex immunoassay was used to test clinical venous serum samples
where it showed remarkable consistency with clinical test results
in methodological comparison and the diagnosis of polycystic ovary
syndrome. In addition, we successfully applied the ultrasensitive
capability of this assay to the simultaneous testing and evaluation
of four proteins in fingertip blood as well as urine samples, in which
the urinary AMH level (1.42–156 pg/mL) was measured and assessed
quantitatively for the first time.